| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |